Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引：4
|
作者：
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构：
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2023年 / 19卷 / 11期
关键词：
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I：
10.1080/17425255.2023.2277758
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：733 / 739
页数：7
相关论文
共 50 条
  • [41] Dual tyrosine kinase inhibitors
    Govindan, R
    LUNG CANCER, 2004, 46 : S8 - S8
  • [42] Spleen tyrosine kinase inhibitors
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 181 - 181
  • [43] Nanomedicine of tyrosine kinase inhibitors
    Smidova, Veronika
    Michalek, Petr
    Goliasova, Zita
    Eckschlager, Tomas
    Hodek, Petr
    Adam, Vojtech
    Heger, Zbynek
    THERANOSTICS, 2021, 11 (04): : 1546 - 1567
  • [44] Hepatotoxicity of tyrosine kinase inhibitors
    Paech, Franziska
    Bouitbir, Jamal
    Krahenbuhl, Stephan
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 434 - 435
  • [45] Tyrosine Kinase Inhibitors for the Elderly
    Hohenforst-Schmidt, Wolfgang
    Zarogoulidis, Paul
    Steinheimer, Michael
    Benhassen, Naim
    Tsiouda, Theodora
    Baka, Sofia
    Yarmus, Lonny
    Stratakos, Grigoris
    Organtzis, John
    Pataka, Athanasia
    Tsakiridis, Kosmas
    Karapantzos, Ilias
    Karapantzou, Chrysanthi
    Darwiche, Kaid
    Zissimopoulos, Athanasios
    Pitsiou, Georgia
    Zarogoulidis, Konstantinos
    Man, Yan-Gao
    Rittger, Harald
    JOURNAL OF CANCER, 2016, 7 (06): : 687 - 693
  • [46] Tyrosine Kinase Inhibitors and Pregnancy
    Abruzzese, Elisabetta
    Trawinska, Malgorzata Monika
    Perrotti, Alessio Pio
    De Fabritiis, Paolo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01):
  • [47] Hepatotoxicity of tyrosine kinase inhibitors
    Paech, F.
    Bouitbir, J.
    Kraehenbuehl, S.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S265 - S265
  • [48] Tyrosine kinase inhibitors.
    He, W
    Myers, MR
    Spada, AP
    Hanney, BA
    Setzer, N
    Mailliet, P
    Gontier, S
    Guegen, JC
    Cans, P
    Orton, E
    Cheve, M
    Kubiak, GG
    Shah, HG
    O'Brien, MK
    Bilder, GE
    Allen, E
    Bissery, MC
    Page, K
    Natarajan, C
    Jayyosi, Z
    Kelley, MF
    Toutain, H
    Constan, A
    Amin, D
    Needle, S
    Galczenski, H
    Wang, W
    Perrone, MH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U57 - U57
  • [49] The synthesis of tyrosine kinase inhibitors
    He, W
    Myers, MR
    Spada, AP
    Hanney, BO
    Setzer, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U73 - U73
  • [50] Calcineurin inhibitors and hypertension: a role for pharmacogenetics?
    Moes, Arthur D.
    Hesselink, Dennis A.
    Zietse, Robert
    van Schaik, Ron H. N.
    van Gelder, Teun
    Hoorn, Ewout J.
    PHARMACOGENOMICS, 2014, 15 (09) : 1243 - 1251
12345